294 filings
8-K
CELG
Celgene Corporation
22 Nov 19
Completion of Acquisition or Disposition of Assets
5:15pm
8-K
CELG
Celgene Corporation
20 Nov 19
CELGENE Announces plans to transfer listing of Celgene’s Contingent value rights following Closing of Acquisition by Bristol-Myers Squibb
5:25pm
8-K
CELG
Celgene Corporation
31 Oct 19
Celgene Reports Third Quarter 2019
7:37am
8-K
CELG
Celgene Corporation
26 Aug 19
Entry into a Material Definitive Agreement
7:30am
8-K
CELG
Celgene Corporation
30 Jul 19
Celgene Reports Second Quarter 2019
7:42am
8-K
wtrpxph ps8qa
25 Apr 19
Celgene Reports First Quarter 2019
4:53pm
8-K
piiw5dbw b0
12 Apr 19
Celgene Stockholders Approve Proposed Acquisition by Bristol-Myers Squibb
4:08pm
8-K
lkxdh1
4 Apr 19
Other Events
4:14pm
8-K
xj9wmp1dti htsuqbp
29 Mar 19
Celgene Settles U.s. Revlimid®patent Litigation with Alvogen
12:06pm
8-K
yphuc5cc7 lje
26 Mar 19
Other Events
7:20am
8-K
64mlnd0w mnqqpj
8 Mar 19
Regulation FD Disclosure
5:01pm
8-K/A
f66v9z9z9jt4qv 6bh
8 Mar 19
Financial Statements and Exhibits
12:00am
8-K
4geqwn2wt2dwlgtn5 30
31 Jan 19
Results of Operations and Financial Condition
7:34am
8-K/A
z43sb0l
25 Jan 19
Financial Statements and Exhibits
4:30pm
8-K
q1ab7evnyi fb1tvb0
7 Jan 19
Celgene Corporation Announces 2019 Financial Guidance and Key Milestones
7:34am
8-K
ioxftd3 iqs72p
4 Jan 19
Entry into a Material Definitive Agreement
7:39am
8-K
r7sriz91esj79rowcf
3 Jan 19
Bristol-Myers Squibb to Acquire Celgene to Create a Premier
7:07am
8-K
at7xjmy994wyg742pobg
2 Nov 18
Departure of Directors or Certain Officers
4:02pm
8-K
tpz8o8hswh
25 Oct 18
Celgene Reports Third Quarter 2018
7:36am
8-K
y0m aczvl
26 Jul 18
Celgene Reports Second Quarter 2018
7:38am